Crystalvue Medical Corporation

6527 · TWO · Healthcare / Medical Instruments & Supplies

72.80TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close72.80

Open72.80

Day Range72.80 – 73.20

52-Week Range63.57 – 82.65

Volume6.05K

Market Cap1.90B

P/E (TTM)12.99

Forward P/E0.00

EPS5.76

Dividend Yield3.88%

Beta0.71

50-Day Avg74.08

200-Day Avg73.13

About

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOZhong Ping Zhuang
Employees0
HeadquartersNo.116, Zhongshan Road, Taoyuan City, Taiwan, 330, Taiwan
Websitehttps://www.crystalvue.com.tw

Leadership

Zhong Ping ZhuangGM & Director

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	721.61M	795.46M	823.96M	868.03M	949.05M
Growth (%)	-	+10.23%	+3.58%	+5.35%	+9.33%
Cost of Revenue	510.22M	533.71M	557.22M	568.89M	617.17M
Gross Profit	211.39M	261.74M	266.75M	299.14M	331.88M
Gross Margin	29.29%	32.90%	32.37%	34.46%	34.97%
Operating Expense	122.93M	136.94M	149.07M	154.14M	150.93M
Operating Income	88.47M	124.80M	117.68M	145.01M	180.94M
Operating Margin	12.26%	15.69%	14.28%	16.71%	19.07%
EBITDA	-	169.59M	149.73M	189.36M	197.28M
EBITDA Margin	-	21.32%	18.17%	21.81%	20.79%
Net Income	77.24M	115.03M	103.40M	127.15M	146.98M
Net Income Margin	10.70%	14.46%	12.55%	14.65%	15.49%
R&D	49.20M	46.97M	44.67M	45.66M	40.25M
R&D as % of Total Revenue	6.82%	5.90%	5.42%	5.26%	4.24%
Interest Expense	1.17M	998.00K	818.00K	632.00K	453.00K
Interest Expense % of Total Revenue	0.16%	0.13%	0.10%	0.07%	0.05%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	938.51M	1.01B	1.08B	1.18B	1.30B
Total Liabilities	219.61M	237.32M	221.37M	246.39M	266.79M
Total Equity	718.90M	775.66M	857.06M	938.53M	1.03B
Cash	193.78M	176.55M	273.35M	241.64M	132.02M

Cash Flow

Currency: TWD	2019-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	63.26M	51.76M	154.01M	153.06M	139.13M
Capital Expenditure	0	351.95M	9.01M	8.54M	132.05M	185.19M
Free Cash Flow	-	-288.70M	42.75M	145.47M	21.01M	-46.06M
Dividends Paid	-	33.41M	46.30M	56.76M	52.30M	57.02M
FCF to OCF	-	-456.40%	82.59%	94.45%	13.73%	-33.10%
Dividend Paid to FCF	-	-11.57%	108.29%	39.02%	248.87%	-123.80%

Earnings

Report Date	Nov 14, 2023	Feb 29, 2024
EPS Estimate	1.19	1.38
EPS Actual	0.93	0.71
Surprise	-21.85%	-48.55%
Timing	Pre-market	After-hours

Key Statistics & Ratios

Market Cap1.90B

Enterprise Value1.83B

Trailing P/E12.99

Forward P/E0.00

Price / Sales2.17

Price / Book1.82

EPS5.76

Book Value40.70

Revenue (TTM)874.21M

Gross Profit (TTM)326.00M

EBITDA172.13M

Profit Margin16.99%

Operating Margin20.99%

Return on Equity14.95%

Return on Assets8.10%

Shares Outstanding25.34M

Shares Float14.76M

Beta0.71

Dividend Yield3.88%

Dividend Rate2.90

Payout Ratio39.05%

Dividends

20261×

2.90Jul 21, 2026

20251×

2.25Jul 24, 2025

20241×

2.06Jul 11, 2024

20231×

2.40Jul 25, 2023

20221×

1.85Jul 1, 2022

20211×

1.33Sep 3, 2021

20201×

2.43Jul 7, 2020

20191×

1.64Aug 5, 2019

20181×

0.96Jul 19, 2018

20171×

0.95Aug 3, 2017

20161×

1.14Aug 25, 2016

20151×

0.33Jul 23, 2015

Stock Splits

Jul 25, 20231050:1000